Molecular pathways for antigenic peptide generation by ER aminopeptidase 1

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Endoplasmic Reticulum aminopeptidase 1 (ERAP1) is an intracellular enzyme critical for processing peptides presented by MHC class I molecules.
• ERAP1 activity profoundly impacts the cell-surface immunopeptidome and epitope immunodominance, but its precise mechanisms remain unclear.
• Understanding ERAP1's role is crucial for deciphering immune responses and associations with autoimmune diseases and cancer.

Purpose of the Study:

• To review and analyze the proposed mechanisms by which ERAP1 influences the immunopeptidome.
• To discuss the two main pathways of ERAP1 activity: peptide trimming in solution versus trimming while bound to MHC class I.
• To explore the implications of ERAP1's mechanistic details for therapeutic strategies and disease associations.

Main Methods:

• Review of existing scientific literature and evidence supporting the two proposed pathways of ERAP1 action.
• Comparative analysis of the proposed mechanisms of peptide trimming and binding to MHC class I.
• Discussion of the potential complementarity and relative importance of the identified pathways.

Main Results:

• Two distinct pathways for ERAP1-mediated peptide generation are supported by current evidence: trimming in solution and trimming while peptides are partially bound to MHC class I.
• Peptide binding to MHC class I can compete with further ERAP1 trimming, influencing the final immunopeptidome.
• Both pathways contribute to the generation of peptides presented on MHC class I, affecting immune recognition.

Conclusions:

• ERAP1 plays a complex role in shaping the immunopeptidome through distinct trimming pathways.
• Elucidating ERAP1's precise mechanisms is essential for developing targeted therapies and understanding its link to diseases.
• Further research into the interplay between ERAP1 pathways and MHC class I binding is warranted.